Silvercrest Asset Management Group LLC Cv Rx, Inc. Transaction History

Silvercrest Asset Management Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$6.49 - $19.2 $1.67 Million - $4.94 Million	-257,297 Reduced 50.0%	257,297 $3.08 Million
Q2 2024 Aug 14, 2024	BUY	$6.49 - $19.2 $1.69 Million - $5 Million	260,626 Added 102.62%	514,594 $6.17 Million
Q1 2024 May 15, 2024	BUY	$17.99 - $30.49 $1.89 Million - $3.21 Million	105,198 Added 70.71%	253,968 $4.62 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $33.01 $1.74 Million - $4.91 Million	148,770 New	148,770 $4.68 Million

14.4M

56.3K

41.8K

Ticker CVRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,576,200
Market Cap $292M
Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.